当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 202025
编号:13810591
探讨催产素生物学功能的相关研究进展(2)
http://www.100md.com 2020年9月5日 《中西医结合心血管病电子杂志》 202025
     [5] Petersson M,Cardiovascular effects of oxytocin [J].Prog Brain Res,2002,139:281-288.

    [6] Ma H,Jones K R,Guo R,et al.Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure:role of endoplasmic reticulum stress [J].Clin Exp Pharmacol Physiol,2010,37(4):460-465.

    [7] Rowinsky E K,Eisenhauer E A,Chaudhry V,et al.Clinical toxicities encountered with paclitaxel (Taxol) [J].Semin Oncol,1993,20(4 Suppl 3):1-15.

    [8] Pai V B,Nahata M C.Cardiotoxicity of chemotherapeutic agents:incidence, treatment and prevention [J]. Drug Saf,2000,22(4):263-302.

    [9] Khan S,Chen C L,Brady M S,et al.Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma [J].J Clin Oncol,2012,30(18):e163-e164.

    [10] Ryberg M.Recent advances in cardiotoxicity of anticancer therapies [J].Am Soc Clin Oncol Educ Book,2012:555-559.

    [11] Moore R A,Adel N,Riedel E,et al.High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy:a large retrospective analysis [J].J Clin Oncol,2011,29(25):3466-3473.

    [12] Kounis N G,Cervellin G,Lippi G.Cisplatin-induced bradycardia: cardiac toxicity or cardiac hypersensitivity and Kounis syndrome? [J].Int J Cardiol,2016,202:817-818., http://www.100md.com(白红文 孙洪涛)
上一页1 2